Product Details

Triumeq##

Dolutegravir (Dolutegravir Sodium); Abacavir; Lamivudine
50 mg; 600 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

Glaxo Smithkline Consumer Nigeria PLC

NRN

B4-8285

Status

Active


Composition

Each film coated tablet contains: Dolutegravir 50 mg as Dolutegravir Sodium, Abacavir 600 mg as Abacavir Sulfate, Lamivudine 300 mg Excipients q.s.  

ATC Code

J05AR13  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 30's (in HDPE bottle)  

Product Description

Tablet Purple, biconvex, oval tablets debossed with "572 Trı" on one side TRIUMEQ DOLUTEGRAVIR/ABACAVIR/LAMIVUDINE 50 mg of dolutegravir as dolutegravir sodium, 600 mg of abacavir as abacavir sulfate and 300 mg of lamivudine B4-8285 Drugs Imported Products 1*30tablets POM 1 30/01/2023 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 delphine.u.onyeaso@gsk.com GLAXO OPERATIONS UK LTD , PRIORY STREET ,WARE HERTFORDSHIRE SG12 0DJ, UNITED KINGDOM . , GLAXO OPERATIONS UK LTD , PRIORY STREET ,WARE HERTFORDSHIRE SG12 0DJ, UNITED KINGDOM . , United Kingdom

Manufacturer Name

Glaxo Operations UK Limited

Manufacturer Country

UNITED KINGDOM  

Approval Date

2023-04-26  

Expiry Date

2028-04-25